deltatrials
Unknown PHASE3 INTERVENTIONAL 2-arm NCT04290013

Effects of Tranexemic Acid Versus Norethisterone Acetate on Endometrial Vasculature .

Effect of Tranexemic Acid and Norethisterone Acetate on Endometrial Vasculature in Women With Dysfunctional Uterine Bleeding.

Sponsor: Cairo University

Updated 6 times since 2020 Last updated: Mar 13, 2020 Started: Apr 22, 2020 Primary completion: Oct 1, 2020 Completion: Dec 31, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Dysfunctional Uterine Bleeding, this trial is ongoing. The trial is conducted by Cairo University and has accumulated 6 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshotNot Yet Recruiting~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Apr 2022 · 15 months · monthly snapshotNot Yet Recruiting~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown StatusUnknown

  3. Apr 2022 — Jul 2024 [monthly]

    Unknown Status PHASE3

    Status: Not Yet RecruitingUnknown Status

  4. Jan 2021 — Apr 2022 [monthly]

    Not Yet Recruiting PHASE3

  5. Apr 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE3

Show 1 earlier version
  1. Mar 2020 — Apr 2020 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cairo University
Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.